Ligand Pharmaceuticals Inc (LGND)
Cost of Revenue
$3.21M
Quarterly · Period ending: · USD
LGND Cost of Revenue
Latest reported$3.21Mperiod ending
Latest reported$3.21Mperiod ending
LGND Quarterly Cost of Revenue ($5.90M → $3.21M)
Quarterly cost of revenue
High-resolution chart · PNG
LGND cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 3,214,000 | |
| 2,075,000 | |
| -25,988,500 | |
| 24,820,000 | |
| 2,907,000 | |
| 4,849,000 | |
| 2,837,000 | |
| 12,495,000 | |
| -15,326,000 | |
| 11,068,000 | |
| 1,664,000 | |
| 3,485,000 | |
| 1,669,000 | |
| 3,717,000 | |
| 21,614,000 | |
| 14,153,000 | |
| 12,361,000 | |
| 4,699,000 | |
| 11,984,000 | |
| 11,446,000 | |
| 30,593,000 | |
| 8,153,000 | |
| 11,739,000 | |
| 6,353,000 | |
| 7,644,000 | |
| 4,683,000 | |
| 1,937,000 | |
| 3,147,000 | |
| 2,405,000 | |
| 3,858,000 | |
| 2,955,000 | |
| 1,460,000 | |
| 1,134,000 | |
| 788,000 | |
| 1,738,000 | |
| 2,385,000 | |
| 903,000 | |
| 341,000 | |
| 2,896,000 | |
| 999,000 | |
| 720,000 | |
| 955,000 | |
| 884,000 | |
| 1,250,000 | |
| 2,600,000 | |
| 1,074,000 | |
| 4,002,000 | |
| 1,496,000 | |
| 1,186,000 | |
| 2,451,000 | |
| 1,317,000 | |
| 2,538,000 | |
| 1,214,000 | |
| 663,000 | |
| 2,328,000 | |
| 683,000 | |
| 435,000 | |
| 155,000 | |
| 2,058,000 | |
| 703,000 | |
| 1,623,000 | |
| 525,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -15,235,000 | |
| 15,235,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 5,874,000 | |
| 5,800,000 | |
| 10,266,000 | |
| 9,740,000 | |
| 8,308,000 | |
| 9,807,000 | |
| 10,667,000 | |
| 11,065,000 | |
| 10,044,000 | |
| 11,011,000 | |
| 9,926,000 | |
| 8,823,000 | |
| 8,667,000 | |
| 8,565,000 | |
| 7,766,000 | |
| 6,620,000 | |
| 5,519,000 | |
| 5,646,000 | |
| 4,681,000 | |
| 4,460,000 | |
| 4,386,000 | |
| 3,645,000 |